Career development I: Combining science & industry
About Thijn Brummelkamp
Thijn Brummelkamp develops and uses genetic technologies to identify genes that are relevant for human disease. For example an approach for genetics in haploid human cells was developped and used to identify the entry receptor for Ebola virus (Carette et al, Nature, 2011), to reognize a new step in the picornavirus life cycle (Staring et al, Nature, 2017), to assign Vasohibins as long-sought enzymes modifiers of the cytoskeleton (Nieuwenhuis et al, Science 2017) and to implicate genes in pathways relevant for cancer immunotherapy (Mezzadra et al, Nature, 2017; Logtenberg et al, Nature Medicine, 2019).
He was chosen as one of the world's top 35 Young Innovators by MIT's Technology Review Magazine (2005), received EMBO’s Gold Medal 2013 and the KNAW Ammodo award (2015). Thijn Brummelkamp is a co-founder of 3 biotech companies, Haplogen Genomics (acquired in 2015 by Horizon Discovery UK), Haplogen (partnered in 2018 with Bayer to develop antiviral agents) and Scenic Biotech B.V. (founded in 2017).
Jumpstart your career
Join BioBusiness Summer School to jumpstart your career in Life Sciences by gaining knowledge of business aspects such as product development, IPR, finance and business models. The next edition of the summer school will be organised online from 22-26 June 2020.
The BioBusiness Summer School is a programme tailored to bridge the gap. By immersing yourself in the business aspects of Life Sciences during this programme, you will learn the basic knowledge of BioBusiness, gain insight in the world of Life Sciences companies, meet leading business leaders and increase your international network.